Cian Healthcare (BOM:542678) EPS (Basic): ₹-31.68 (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542678 Cian Healthcare Ltd BOM:542678
49 GF Score
Price ₹9.55
GF Value ₹82.28
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Cian Healthcare EPS (Basic)?

Cian Healthcare BOM:542678 49 EPS (Basic) is ₹-31.68 as of Mar. 2026. GuruFocus rates BOM:542678 with a GF Score™ of 49/100 and a GF Value™ of ₹82.28 (Possible Value Trap). The stock has 5 warning signs investors should review.

Cian Healthcare's basic earnings per share (Basic EPS) for the six months ended in Mar. 2026 was ₹-7.19. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-31.68.

Cian Healthcare's EPS (Diluted) for the six months ended in Mar. 2026 was ₹-7.19. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-31.68.

Cian Healthcare's EPS without NRI for the six months ended in Mar. 2026 was ₹1.87. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2026 was -22.47.

During the past 3 years, the average EPS without NRI Growth Rate was -29.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 11 years, Cian Healthcare's highest 3-Year average EPS without NRI Growth Rate was 65.00% per year. The lowest was -64.70% per year. And the median was -29.40% per year.

Cian Healthcare  (BOM:542678) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cian Healthcare EPS (Basic) Related Terms

Cian Healthcare EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Cian Healthcare's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cian Healthcare EPS (Basic) Chart

Cian Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -32.22 11.81 4.96 -10.39 -9.32

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.56 -90.53 -3.09 -24.49 -7.19
BOM:542678
49GF Score
Cian Healthcare Ltd BOM:542678
EPS (Basic) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cian Healthcare EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Cian Healthcare's Basic EPS for the fiscal year that ended in Mar. 2026 is calculated as

Basic EPS (A: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-232.927-0)/1.715
=-135.82

Cian Healthcare's Basic EPS for the quarter that ended in Mar. 2026 is calculated as

Basic EPS (Q: Mar. 2026 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-179.711-0)/1.715
=-104.79

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-31.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of ₹-31.68 mean?
Cian Healthcare (BOM:542678) has a EPS (Basic) of ₹-31.68 as of Mar. 2026. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Cian Healthcare and its competitors.
Is Cian Healthcare's EPS (Basic) too high?
Cian Healthcare's current EPS (Basic) is ₹-31.68. Overall, Cian Healthcare has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's EPS (Basic) compare to ZTS and UTHR?
Cian Healthcare's EPS (Basic) of ₹-31.68 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Drug Manufacturers company?
A good EPS (Basic) depends on the Drug Manufacturers industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Cian Healthcare and its competitors. Cian Healthcare's current EPS (Basic) is ₹-31.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Possible Value Trap. The stock's GF Value™ is ₹82.28, compared to a current price of ₹9.55 — trading 88.4% below its estimated fair value. The current EPS (Basic) is ₹-31.68. Cian Healthcare's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current EPS (Basic) is ₹-31.68 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cian Healthcare (BOM:542678) Overvalued in 2026?

Based on GuruFocus' analysis, Cian Healthcare stock appears to be undervalued. The current stock price of ₹9.55 is trading 88.4% below its estimated GF Value™ of ₹82.28. GuruFocus considers Cian Healthcare to be Possible Value Trap.

Key valuation signals for BOM:542678:

  • EPS (Basic): ₹-31.68
  • GF Value™: ₹82.28 vs. price of ₹9.55 (88.4% below fair value)
  • GF Score™: 49/100 with 5 warning signs

No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cian Healthcare Business Description

Address Mundhwa Kharadi Road, Kirtane Baugh, Office No 301 Konark Icon 3rd Floor, Magarpatta Hadapsar, Mundhwa, Pune, MH, IND, 411036
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
49GF Score

Get the complete analysis for BOM:542678

EPS (Basic) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹9.55
Price
₹82.28
GF Value